News
March 16, 2022 – Legislative Update
Cerus Encouraged by the NDAA FY2022 Consideration of PR Resuscitative Products for Clinical Guidelines to Treat Obstetric Hemorrhage
Sept 20, 2021 – Press Release
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
Aug 20, 2021 – Announcement
First Patient Treated with
INTERCEPT Fibrinogen Complex
Aug 10, 2021 – Press Release
Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products
Aug 3, 2021 – Press Release
Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex
Nov 30, 2020 – Press Release
Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation
Oct 31, 2020 – Press Release
Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate